Industrial systems cybersecurity company Claroty raises $60M Series B led by Singapore’s Temasek, bringing total investment to $93M (Zaid Shoorbajee/Cyberscoop)

June 11, 2018

Zaid Shoorbajee / Cyberscoop: Industrial systems cybersecurity company Claroty raises $60M Series B led by Singapore’s Temasek, bringing total investment to $93M  —  Claroty, a industrial control systems cybersecurity company, announced on Monday that it raised $60 million in Series B funding from a diverse group of investors … Source: http://www.techmeme.com

Read More >>

Industrial systems cybersecurity company Claroty raises $60M Series B led by Singapore’s Temasek, bringing total investment to $93M (Zaid Shoorbajee/Cyberscoop)

June 11, 2018

Zaid Shoorbajee / Cyberscoop: Industrial systems cybersecurity company Claroty raises $60M Series B led by Singapore’s Temasek, bringing total investment to $93M  —  Claroty, a industrial control systems cybersecurity company, announced on Monday that it raised $60 million in Series B funding from a diverse group of investors … Source: http://www.techmeme.com

Read More >>

Industrial systems cybersecurity company Claroty raises $60M Series B led by Singapore’s Temasek, bringing total investment to $93M (Zaid Shoorbajee/Cyberscoop)

June 11, 2018

Zaid Shoorbajee / Cyberscoop: Industrial systems cybersecurity company Claroty raises $60M Series B led by Singapore’s Temasek, bringing total investment to $93M  —  Claroty, a industrial control systems cybersecurity company, announced on Monday that it raised $60 million in Series B funding from a diverse group of investors … Source: http://www.techmeme.com

Read More >>

A Serious New Hurdle For CRISPR: Edited Cells Might Cause Cancer, Find Two Studies

Editing cell genomes with CRISPR-Cas9 might increase the risk of developing cancer, two studies published Monday warn. From a report: Editing cells’ genomes with CRISPR-Cas9 might increase the risk that the altered cells, intended to treat disease, will trigger cancer, two studies published on Monday warn — a potential game-changer for the companies developing CRISPR-based therapies. In the studies, published in Nature Medicine, scientists found that cells whose genomes are…

June 11, 2018
Read More >>

A Serious New Hurdle For CRISPR: Edited Cells Might Cause Cancer, Find Two Studies

Editing cell genomes with CRISPR-Cas9 might increase the risk of developing cancer, two studies published Monday warn. From a report: Editing cells’ genomes with CRISPR-Cas9 might increase the risk that the altered cells, intended to treat disease, will trigger cancer, two studies published on Monday warn — a potential game-changer for the companies developing CRISPR-based therapies. In the studies, published in Nature Medicine, scientists found that cells whose genomes are…

June 11, 2018
Read More >>

A Serious New Hurdle For CRISPR: Edited Cells Might Cause Cancer, Find Two Studies

Editing cell genomes with CRISPR-Cas9 might increase the risk of developing cancer, two studies published Monday warn. From a report: Editing cells’ genomes with CRISPR-Cas9 might increase the risk that the altered cells, intended to treat disease, will trigger cancer, two studies published on Monday warn — a potential game-changer for the companies developing CRISPR-based therapies. In the studies, published in Nature Medicine, scientists found that cells whose genomes are…

June 11, 2018
Read More >>